Over the last six months, several major studies have laid bare the threat posed by antimicrobial … More
In the past 20 years, cancer medicine has been revolutionized by an array of new treatments, ranging from monoclonal antibodies to novel immunotherapies like CAR T-cell therapy, and targeted therapies like tyrosine kinase inhibitors. Some have played such a major role in improving survival rates that they have now been added to the WHO Model List…
Continue Reading
News Source: www.forbes.com
Leave a Reply